silybin has been researched along with Cardiomegaly in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ai, W; Bai, X; Bian, ZY; Huang, H; Li, H; Liu, C; Tang, QZ; Yan, L; Yin, L; Zhang, Y | 1 |
Anestopoulos, I; Kavo, A; Kortsaris, A; Lazou, A; Panayiotidis, M; Pappa, A; Tentes, I | 1 |
2 other study(ies) available for silybin and Cardiomegaly
Article | Year |
---|---|
Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Cardiomegaly; Cell Shape; Cells, Cultured; Dose-Response Relationship, Drug; ErbB Receptors; Fibrosis; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Silybin; Silymarin | 2010 |
Silibinin protects H9c2 cardiac cells from oxidative stress and inhibits phenylephrine-induced hypertrophy: potential mechanisms.
Topics: Animals; Antioxidants; Cardiomegaly; Carrier Proteins; Cell Line; Cell Survival; DNA Fragmentation; Heart; Hydrogen Peroxide; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxidative Stress; Phenylephrine; Phosphorylation; Plant Extracts; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Rhodamines; Signal Transduction; Silybin; Silybum marianum; Silymarin; Up-Regulation | 2013 |